#pancreatic cancer

Triple Combo for Pancreatic Cancer

Individuals considered at high risk were 25 times more likely to develop pancreatic cancer within three years.

New studies shed light on rates of depression, anxiety and the risks of self-harm and suicide in people diagnosed with cancer.

In a mouse study, a ketogenic diet tripled survival time compared with chemotherapy alone.

The discovery that pancreatic cancers can be sustained by hyaluronic acid is challenging to translate into therapies. Here’s why.

The success of the mRNA COVID-19 vaccines could help accelerate clinical research on vaccines to treat cancer.

“Having a caregiver or advocate by your side is so important.” As is a keeping binder to organize the deluge of pancreatic cancer data.

Damon Runyon Cancer Research Foundation scientists work to develop drugs for people with KRAS-driven cancers.

In animal studies, calorie-restricted diets slowed pancreatic tumor growth more than did high-fat ketogenic diets.

Scientists build on the finding that pancreatic cancer cells use GOT1 to reroute energy and build more cancer cells.

A combination of three immunotherapy drugs shows promise in animal studies.

National Cancer Institute-supported studies are testing ways to pick out people whose diabetes might be a sign of pancreatic cancer.

The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.

Since her mother died of pancreatic cancer, actress Keesha Sharp wants to teach others about the robust research on the disease’s treatment.

Experimental monoclonal antibody sotigalimab shows promising results in a Phase I study.

The Damon Runyon Cancer Research Foundation awards $2.8 million to innovative early career scientists.